U.S. Viscosupplementation Market Size & Outlook, 2025-2033
Related Markets
U.S. viscosupplementation market highlights
- The U.S. viscosupplementation market generated a revenue of USD 1,794.7 million in 2024 and is expected to reach USD 2,973.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 5.4% from 2025 to 2033.
- In terms of segment, single injection was the largest revenue generating product in 2024.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2024 | USD 1,794.7 million |
| Market revenue in 2033 | USD 2,973.3 million |
| Growth rate | 5.4% (CAGR from 2025 to 2033) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.9% of the global viscosupplementation market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. viscosupplementation market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 137.4 million by 2033.
Single injection was the largest segment with a revenue share of 47.89% in 2024. Horizon Databook has segmented the U.S. viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.
According to CDC, in 2013–2015, 54 million people in the U.S. were reported to be diagnosed with some form of arthritis. The condition has limited the activities of around 24 million adults and is responsible for severe joint pain in about 15 million adults.
The most common form of arthritis is osteoarthritis followed by rheumatoid arthritis, gout, and fibromyalgia. The rapid rise in geriatric population has led to increase in incidence of osteoarthritis, thus propelling demand for joint-injectable products.
According to Population Reference Bureau, the population of Americans aged 65 or older is projected to increase by twofold from 46 million in 2016 to 98 million by 2060. Multiple-injection products have existed in the market for a long time and, hence, are highly preferred.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lifecore Biomedical Inc | View profile | 459 | 3515 Lyman Boulevard, Chaska, MN, United States, 55318 | https://www.lifecore.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| LG Chem | View profile | 10001+ | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | https://www.lgchem.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
U.S. viscosupplementation market size, by product, 2021-2033 (US$M)
U.S. Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
